Olux-E Approval History
- FDA approved: Yes (First approved January 12th, 2007)
- Brand name: Olux-E
- Generic name: clobetasol propionate
- Dosage form: Foam
- Company: Stiefel Laboratories, Inc.
- Treatment for: Psoriasis, Eczema
Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.
Development History and FDA Approval Process for Olux-E
|Jan 12, 2007||Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.